Finemedix Co., Ltd. (KOSDAQ:387570)
6,130.00
+30.00 (0.49%)
At close: Jun 4, 2026
Finemedix Revenue
Finemedix had revenue of 2.23B KRW in the quarter ending March 31, 2026, with 17.54% growth. This brings the company's revenue in the last twelve months to 9.86B, down -2.28% year-over-year. In the year 2025, Finemedix had annual revenue of 9.52B, down -4.39%.
Revenue (ttm)
9.86B
Revenue Growth
-2.28%
P/S Ratio
3.32
Revenue / Employee
n/a
Employees
n/a
Market Cap
32.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.52B | -437.66M | -4.39% |
| Dec 31, 2024 | 9.96B | -193.73M | -1.91% |
| Dec 31, 2023 | 10.15B | 2.01B | 24.71% |
| Dec 31, 2022 | 8.14B | 888.41M | 12.25% |
| Dec 31, 2021 | 7.25B | -656.61M | -8.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Synergy Innovation | 112.84B |
| DENTIS CO.,Ltd | 111.96B |
| Corentec | 102.38B |
| M.I.TECH Co.,Ltd | 66.63B |
| BIOBIJOU | 24.92B |
| Bio Protech | 20.58B |
| Alpha AI | 15.79B |
| Sanigen Co. | 14.45B |